Comparison of Two Different Doses of Ondansetron plus Dexamethasone in the Prophylaxis of Cisplatin-lnduced Emesis

Oncology (Switzerland)

Volumn 54, Issue 1, 1997, Pages 1-6

  Pectasides, Dimitris ^a   Mylonakis, Alexander ^a   Varthalitis, John ^a   Kostopoulou, Mary ^a   Constantinou, Andreas ^a   Papazachariou, Kathrin ^a   Antoniou, Fotini ^a   Dimitriadis, Michael ^a   Athanassiou, Athanassios ^a  

^a METAXA CANCER HOSPITAL   (Greece)

Author keywords

Antiemetic protection; Cisplatin; Nausea; Ondansetron; Vomiting

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DEXAMETHASONE; IFOSFAMIDE; ONDANSETRON;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ACUTE DISEASE; ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; ONDANSETRON; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VOMITING;

EID: 0031060234     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227651     Document Type: Article

References (22)

1. Laszlo J: Emcsis as a critical problem in chemotherapy, N Engl J Med 1981;305:948-949.
2. Gralla RJ, Itri LM, Pisko SE, Squillante AE, Kelscn DP, Braun DW, Bordin LA, Braun TJ, Young CW: Antiemetic efficacy of high-dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with che-motherapy-induced nausea and vomiting, N Engl J Med 1981;305:905-909.
3. Milne RJ, Heel RC: Ondansetron, Therapeutic use as an antiemetic, Drugs 1991,41:574-595.
4. Gandara DR: Progress in the control of acute and delayed emesis induced by cisplatin, Eur J Cancer 1991;27(suppl 1):509-511.
5. Hainsworth J, Harvey W, Pendergrass K, Ka-simis B, Obion D: A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy, J Clin Oncol 1991;9:721-728.
6. Marty M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N, Pujadc-Lavraine E, Paule B, Paes D, Bous J: Comparison of the 5-hydroxy trypt-amine (serotonin) antagonist ondansetron (GR 38032 F) with high-dose metoclopramide in the control of cisplatin-induced emesis, N Engl J Med 1990;322:816-821.
7. Marty M: Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting, Eur J Cancer Clin Oncol 1989;25:41-45.
8. Italian Group for Antiemetic Research, Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emcsis, Lancet 1992;340:96-99.
9. Markham A, Sorkin EM: Ondansetron: An update of its therapeutic use in chemotherapy induced and postoperative nausea and vomiting, Drugs 1993;45:931-952.
10. Roila R, Tonato M, Cognetti F, Cortesi E, Fa-valli G, Marangalo M, Amdori D, Bella MA, Gramazio V, Donati D: Prevention of cisplatin induced emesis: A double blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone, J Clin Oncol 1991;9:675-678.
11. Smith DB, Newlands ES, Rustin GJS, Begent RHJ, Howells N, McQuade B, Bagshawe KD: Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy, Lancet 1991;338:487-490.
12. Tonato M: Ondansetron plus dexamethasone: An effective combination in high-dose cisplatin therapy, Eur J Cancer 1991;27(suppl 1):S12-S14.
13. Beck TM, Hesketh PJ, Madajewicz S, Navari RM, Pendergrass K, Lester EP, Kish JA, Murphy WK, Hainsworth JD, Gandara DR, Brick-er U, Keller AM, Mortimer J, Galvin DV, House KW, Bryson JC: Stratified, randomised, double-blind comparison of intravenous ondansetron administered as a multiple dose regimen versus two single-dose regimens in the prevention of cisplatin induced nausea and vomiting, J Clin Oncol 1992;10:1069-1075.
14. Seynaeve C, Schuller D, Brunner KW, Porte-dar H, Van Belle S, Sevelda P, Christmann D, Schmidt M, Kitchener H, Paes D, de Mulder PHM: Comparison of the antiemetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose in acute cisplatin-induced emesis, Br J Cancer 1992;66:192-197.
15. Ruff P, Paska W, Geodhals L, Povillart P, Riviere A, Vorobiof D, Bloch B, Jones A, Martin C, Brunet R, Butcher M, Forster J, McQuade B: Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: A multiccntrc, double-blind, randomized, parallel-group study, Oncology 1994;51:113-118.
16. Joss R, Buscr K, Piquet D, Aapro M, Cavalli F, Haelfiger JM, Jungi W, Bauer J, Weber T, Verity L, Butcher M: A randomised, double blind comparison of oral ondansetron and placebo in the prophylaxis of CMF-induccd nausea and vomiting, Perugia International Cancer Conference III, Supportive Therapy: Challenges for the '90s, Perugia, June 1990.
17. Marty M, d’Allens H, Perez EA, Hesketh PJ: Etude randomisée en double-insu comparant l’efficacité de l’ondansétron selon deux modes d'administration: injection unique et perfusion continue, Cahier Cancer 1990;2:541-546.
18. Fox S, Einhom L, Cox E, Powell N, Abdy A: Ondansetron versus ondansetron, dexamethasone and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy, J Clin Oncol 1993;12:2391-2395.
19. Gardara DR, Harvey WH, Monaghan GG, Perez EA, Hesketh PJ: Delayed emesis following high-dose cisplatin, A double-blind randomized comparative trial of ondansetron (GR 38032 F) versus placebo, Eur J Cancer 1993; 29a(suppl 1):s35-s38.
20. Kirchner V, Aapro M, Alberto P: Ondansetron for the prevention of cancer treatment induced nausea and vomiting in multiple cycles of treatment (abstract), Eur J Cancer 1991;suppl 2: S297.
21. Marty M, Richard A, d’Allens H: Efficacy of repeated courses of ondansetron (OND) in the prevention of cisplatin-induced emesis (abstract), Eur J Cancer 1991;suppl 2:S299.
22. Werner K, Finn AI, Gandara DR: Maintenance of antiemetic effectiveness with multiple courses of GR 38032 F and cisplatin (DDP) (abstract), Proc Am Soc Oncol 1989;8:327.